| Title : Rocuronium antagonized by sugammadex for series of electroconvulsive therapy (ECT) in a patient with pseudocholinesterase deficiency - Batistaki_2011_J.ECT_27_e47 |
| Author(s) : Batistaki C , Kesidis K , Apostolaki S , Kostopanagiotou G |
| Ref : J Ect , 27 :e47 , 2011 |
|
Abstract :
We report the anesthetic management of a patient with catatonic schizophrenia and pseudocholinesterase deficiency, using the nondepolarizing neuromuscular blocking drug, rocuronium, reversed by its specific reversal agent, sugammadex, for a series of electroconvulsive therapy sessions. Rocuronium and sugammadex were used every 48 hours for 8 consecutive times and proved to be an effective and safe combination in a situation where succinylcholine was contraindicated. |
| PubMedSearch : Batistaki_2011_J.ECT_27_e47 |
| PubMedID: 21206368 |
| Inhibitor | Rocuronium |
| Chemical | Sugammadex |
Batistaki C, Kesidis K, Apostolaki S, Kostopanagiotou G (2011)
Rocuronium antagonized by sugammadex for series of electroconvulsive therapy (ECT) in a patient with pseudocholinesterase deficiency
J Ect
27 :e47
Batistaki C, Kesidis K, Apostolaki S, Kostopanagiotou G (2011)
J Ect
27 :e47